Incepta Pharmaceuticals launches generic version of Sovaldi

Incepta Pharmaceuticals has brought a generic version of the drug Sovaldi, of the Gilead Sciences, which is being used in treatment of hepatitis C, is a very popular drug. The generic version of the drug will be sold at a price of $10.

The generic drug of Sovaldi is named as Hopetavir and the cost of the drug for a period of 12 weeks will be $900. Cost of Gilead Sciences Inc.'s Sovaldi is very high. "Gilead is aware of unauthorized generic versions of sofosbuvir being offered in the marketplace .We're focused on enabling our eleven Indian generic partners to launch their authorized generic versions as soon as possible", the company said in an e-mail.

So far, it was the most successful drug for treating hepatitis C. And the cost of this drug for a period of twelve weeks was $86,000.

Read more...

Bangladesh: $10 Copy of Gilead Blockbuster Sovaldi Appears in Bangladesh

(Bloomberg) -- A $10 version of Sovaldi, the Gilead Sciences Inc. hepatitis C treatment that sells for $1,000 a pill in the U.S., is now available in Bangladesh and could make its way to other parts of the world where the U.S. company doesn’t have patents.

Incepta Pharmaceuticals Ltd. doesn’t have a license from Gilead and its version was launched last month, said Managing Director Abdul Muktadir. The company also aims to sell the drug overseas, including to parts of Southeast Asia and Africa.

The generic drugmaker has beaten to the market a number of larger Indian competitors that were licensed by Gilead to produce low-cost versions of Sovaldi for 91 countries that are mostly poor. Nations not covered by Gilead’s license, including Thailand, Malaysia and Morocco, and countries where Sovaldi isn’t patented could benefit from the new source of cheap copies.

Read more...